Epifast 1000 Tablet contains Levetiracetam 1000mg, an antiepileptic agent indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby reducing neuronal excitability and preventing seizure propagation. Epifast 1000 is prescribed as adjunctive therapy or monotherapy depending on the clinical scenario and patient response. The medication is rapidly absorbed with high bioavailability and is primarily excreted unchanged via the kidneys, necessitating dose adjustments in patients with renal impairment. Common adverse effects include somnolence, dizziness, fatigue, and behavioral symptoms such as irritability or mood changes, which typically resolve with continued therapy. Epifast 1000 should be administered consistently at the same time daily to maintain therapeutic plasma concentrations. Caution is advised in patients with a history of psychiatric disorders or suicidal ideation. It is contraindicated in individuals with known hypersensitivity to Levetiracetam or any excipients. Regular monitoring of seizure frequency and renal function is recommended during treatment. Epifast 1000 Tablet offers an effective and well-tolerated option for seizure control in diverse patient populations.